Nostopharma: Funding, Investors & Team (Sep 2026)
Nostopharma offers treatment for pathological bone growth that aims to prevent a rare bone disease. Their treatment helps patients generate new bone after surgeries, burns, injuries, and other traumas, allowing healthcare providers to effectively treat their patients.
Nostopharma has raised $500k across 2 funding rounds on record, the most recent a Pre-Seed of $250k announced in Jan 2025.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Nostopharma Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Nostopharma Funding Rounds
Nostopharma raised $250k in an undisclosed round announced in Jun 2023.
1.6 years later, a Pre-Seed of $250k was announced in Jan 2025.
Nostopharma Founders and Leadership Team
Contact details for the Nostopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Nostopharma Funding Compared to Other Health Care Startups
Nostopharma's latest round of $250k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nostopharma in Health Care and Bethesda
Companies Similar to Nostopharma
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
Nostopharma Funding FAQs
What does Nostopharma do?
Nostopharma offers treatment for pathological bone growth that aims to prevent a rare bone disease. Their treatment helps patients generate new bone after surgeries, burns, injuries, and other traumas, allowing healthcare providers to effectively treat their patients.
How much funding has Nostopharma raised?
Nostopharma has raised $500k across 2 rounds on record. The most recent is a Pre-Seed of $250k announced in Jan 2025.
When did Nostopharma last raise funding?
Nostopharma's most recent funding round on record is a Pre-Seed of $250k, announced in Jan 2025.
Who founded Nostopharma?
FundedIQ lists Jelena Jeremic (Founder) at Nostopharma.
Where is Nostopharma headquartered?
Nostopharma is based in Bethesda, Maryland, United States.
How many employees does Nostopharma have?
Nostopharma is in the 1-10 employee band.
How does Nostopharma's funding compare to other Health Care startups?
Nostopharma's latest round of $250k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Nostopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nostopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.